Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors. [electronic resource]
Producer: 20180112Description: 759-67 p. digitalISSN:- 1479-6821
- Adaptor Proteins, Signal Transducing -- metabolism
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Agents, Alkylating -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine -- pharmacology
- Co-Repressor Proteins
- DNA Modification Methylases -- metabolism
- DNA Repair Enzymes -- metabolism
- Dacarbazine -- analogs & derivatives
- Female
- Humans
- Male
- Middle Aged
- Molecular Chaperones
- Neuroendocrine Tumors -- drug therapy
- Nuclear Proteins -- metabolism
- Pancreatic Neoplasms -- drug therapy
- Telomere
- Temozolomide
- Treatment Outcome
- Tumor Suppressor Proteins -- metabolism
- X-linked Nuclear Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.